Literature DB >> 7118990

[Manipulated selective inhibition of microcirculation in cancer tissues].

M von Ardenne, P G Reitnauer.   

Abstract

This paper confirms previous results that hyperglycemia (5 g/l) lasting 250 min, when combined with local hyperthermia (43 degrees C) for the last 100 min, strongly inhibits microcirculation in Yoshida sarcomas and DS-carcinosarcomas. This inhibition occurs independently of heparinization of the animals (700 IU/200 G body weight) so blood coagulation cannot be an important factor in the mechanism of microcirculation inhibition. After inhibition of microcirculation (detected by measuring tissue death after application of Evans' blue) the dye concentration in the tumor tissue increased unspecifically with a certain time delay and was then only slightly lower than in the untreated tumors. The causes of this observation area discussed. The blood volume of the tumors investigated amounted to about 4 vol.-%. The microcirculation of untreated tumors amounted to between 33 and 50% of the microcirculation of normal tissue (muscle). High doses of Evans' blue inhibited blood coagulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118990     DOI: 10.1007/bf00409702

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  A simple method for the quantitative extraction of dye extravasated into the skin.

Authors:  M Harada; M Takeuchi; T Fukao; K Katagiri
Journal:  J Pharm Pharmacol       Date:  1971-03       Impact factor: 3.765

2.  [Selective damage to cancer cells by protein denaturation].

Authors:  M von Ardenne; P G Reitnauer
Journal:  Dtsch Gesundheitsw       Date:  1968-09-05

3.  [A measuring probe for glucose. 4. Measuring of diluted and undiluted full blood samples using a simple method].

Authors:  P G Reitnauer
Journal:  Z Med Lab Diagn       Date:  1978

4.  The use of hyperthermia within the frame of cancer multistep therapy.

Authors:  M von Ardenne; W Krüger
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  [Manipulated selective hemostasis in tumor tissue without blood coagulation].

Authors:  M von Ardenne; P G Reitnauer
Journal:  Naturwissenschaften       Date:  1981-09

6.  Selective inhibition of microcirculation in tumor tissue.

Authors:  M von Ardenne; P G Reitnauer
Journal:  Naturwissenschaften       Date:  1980-03

7.  Hyperthermia and cancer therapy.

Authors:  M von Ardenne
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

8.  On the optimization of local hyperthermy in tumors based on a new radiofrequency procedure. Local hyperthermy of large body areas using the CMT selectotherm method.

Authors:  M von Ardenne; G Böhme; E Kell
Journal:  J Cancer Res Clin Oncol       Date:  1979-06-08       Impact factor: 4.553

9.  [Overacidified tissue and microcirculation (author's transl)].

Authors:  M von Ardenne; P G Reitnauer
Journal:  Arch Geschwulstforsch       Date:  1978

10.  [Photoelectronic recording of Evan's Blue influx into the blood vessels of tumors with selectively evoked hemostasis as compared to healthy tissue. Retardation of dye influx as a criterion of microcirculation inhibition (author's transl)].

Authors:  M von Ardenne; P G Reitnauer
Journal:  Arch Geschwulstforsch       Date:  1980
View more
  3 in total

1.  Hyperthermia and hyperglycemia for manipulated inhibition of tumor microcirculation.

Authors:  M von Ardenne; P G Reitnauer
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Experimental evidence for a hyperthermia-induced breakdown of tumor blood flow during normoglycemia.

Authors:  P Vaupel; W Müller-Klieser; H Gabbert
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

3.  Laser Doppler flux and tissue oxygenation of experimental tumours upon local hyperthermia and/or hyperglycaemia.

Authors:  W K Mayer; M Stohrer; W Krüger; P Vaupel
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.